Cargando…
Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions
Acute myeloid leukaemia (AML) is an aggressive form of blood cancer that carries a dismal prognosis. Several studies suggest that the poor outcome is due to a small fraction of leukaemic cells that elude treatment and survive in specialised, oxygen (O(2))‐deprived niches of the bone marrow. Although...
Autores principales: | Chen, Fangli, Licarete, Emilia, Wu, Xue, Petrusca, Daniela, Maguire, Callista, Jacobsen, Max, Colter, Austyn, Sandusky, George E., Czader, Magdalena, Capitano, Maegan L., Ropa, James P., Boswell, H. Scott, Carta, Fabrizio, Supuran, Claudiu T., Parkin, Brian, Fishel, Melissa L., Konig, Heiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650039/ https://www.ncbi.nlm.nih.gov/pubmed/34791807 http://dx.doi.org/10.1111/jcmm.17027 |
Ejemplares similares
-
Thiosemicarbazide-Substituted Coumarins as Selective Inhibitors of the Tumor Associated Human Carbonic Anhydrases IX and XII
por: Gumus, Arzu, et al.
Publicado: (2022) -
A class of carbonic anhydrase IX/XII – selective carboxylate inhibitors
por: Alhameed, Rakia Abd, et al.
Publicado: (2020) -
Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
por: Onyılmaz, Mehmet, et al.
Publicado: (2022) -
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors
por: Moi, Davide, et al.
Publicado: (2022) -
First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
por: Testa, Chiara, et al.
Publicado: (2022)